BCL2L1 and acute lymphoblastic leukemia: We were intrigued that, despite these changes, MEK inhibition did not induce profound apoptosis but noted that, compared with normal CD34+ hematopoietic cells, BCL2 and BCLX (BCL2L1) were significantly upregulated in B-ALL cells (Figure 2a).